and invasive abilities of HCC cells were attenuated, and the expression of vascular endothelial growth factor (VEGF) was decreased by the silencing of LOX, through the p38 mitogen-activated protein kinase (MAPK) signaling pathway (30). The gene discussed is MAPK14; the disease is hepatocellular carcinoma.